Manchester University NHS Foundation Trust
970 capabilities
Verified Oct 2026
One of 2,018 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Audiology (Hearing and Balance) Centre, Peter Mount Building, Manchester Royal Infirmary, Oxford Road
Manchester M13 9WL , United Kingdom
Manchester M13 9WL , United Kingdom
Accreditation
Active
UKAS
9682
mft.nhs.uk
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
9682
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFAdditional scope documents
Other locations
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Wythenshawe Hospital
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Manchester
Manchester University NHS Foundation Trust
Liverpool
Manchester University NHS Foundation Trust
Wythenshawe
Test Capabilities (970)
| Standard Reference | Description | Category |
|---|---|---|
| Beta 2 Microglobulin | Beta-2-Microglobulin | Biocompatibility (ISO 10993) |
| Luteinising Hormone (LH) | Luteinising Hormone (LH) | Biological / Microbiological |
| Prostate Specific Antigen (PSA) | Prostate Specific Antigen (PSA) | Biological / Microbiological |
| Thyroid Stimulating Hormone (TSH) | Thyroid Stimulating Hormone (TSH) | Biological / Microbiological |
| Amikacin | Amikacin | Chromatography (GC, HPLC) |
| Cortisol | Cortisol | Chromatography (GC, HPLC) |
| Cortisone | Cortisone | Chromatography (GC, HPLC) |
| Gabapentin | Gabapentin | Chromatography (GC, HPLC) |
| HbA1c-IFCC | HbA1c IFCC | Chromatography (GC, HPLC) |
| Pregabalin | Pregabalin | Chromatography (GC, HPLC) |
| Sirolimus | Sirolimus | Chromatography (GC, HPLC) |
| Thiopental | Thiopental | Chromatography (GC, HPLC) |
| Vitamin A | Vitamin A | Chromatography (GC, HPLC) |
| 1,25-Dihydroxy Vitamin D | 1,25-Dihydroxy-Vitamin D | Clinical Chemistry |
| 17 Hydroxy Progesterone | Blood | 17-hydroxy progesterone | Clinical Chemistry |
| 17-Hydroxyprogesterone | Serum | 17-hydroxyprogesterone | Clinical Chemistry |
| 24hr Protein | Urine | 24hr Protein | Clinical Chemistry |
| 3 Methoxytyramine | Urine | 3-Methoxytyramine | Clinical Chemistry |
| 7-Dehydrocholesterol | EDTA plasma, serum | 7-Dehydrocholesterol | Clinical Chemistry |
| ACE | ACE | Clinical Chemistry |
| Albumin | Albumin | Clinical Chemistry |
| Alpha feto protein (AFP) | alpha-Feto-Protein (AFP) | Clinical Chemistry |
| Androstenedione | Androstenedione | Clinical Chemistry |
| Apixaban | Apixaban | Clinical Chemistry |
| C-Peptide | C-Peptide | Clinical Chemistry |
| CA 125 | CA 125 | Clinical Chemistry |
| CA19-9 | Serum | CA19-9 | Clinical Chemistry |
| CEA | CEA | Clinical Chemistry |
| Calcium | Calcium | Clinical Chemistry |
| Cholesterol | Cholesterol : HDL cholesterol ratio | SOP: CS-LAB-CHE-PRO-67 | Clinical Chemistry |
| Collagen | Collagen | Clinical Chemistry |
| Cyclosporin | Cyclosporin | Clinical Chemistry |
| DHEA-S | DHEA-S | Clinical Chemistry |
| Edoxaban | Edoxaban | Clinical Chemistry |
| Fibrinogen | Fibrinogen | Clinical Chemistry |
| Fibrinogen (Clauss) | Fibrinogen (Clauss) | Clinical Chemistry |
| Folate | Folate | Clinical Chemistry |
| Fondaparinux | Fondaparinux | Clinical Chemistry |
| Gamma-Glutamyl transpeptidase | Gamma-Glutamyl-Transpeptidase | Clinical Chemistry |
| Gentamicin | Gentamicin | Clinical Chemistry |
| Globulin | Globulin | Clinical Chemistry |
| Lactate | Lactate | Clinical Chemistry |
| Mycophenolic Acid | Mycophenolic acid | Clinical Chemistry |
| Osmolality | Osmolality | Clinical Chemistry |
| Oxalate | Oxalate | Clinical Chemistry |
| PIVKA | PIVKA | Clinical Chemistry |
| Placental Growth Factor (PIGF) | Placental growth factor (PIGF) | Clinical Chemistry |
| Procalcitonin | Procalcitonin | Clinical Chemistry |
| Quantification of : White blood cells | Quantification of: | Roche Cobas 8000 system | Clinical Chemistry |
| Salicylate | Salicylate | Clinical Chemistry |
| Selenium | Selenium | Clinical Chemistry |
| Teicoplanin | Teicoplanin | Clinical Chemistry |
| Testosterone | Testosterone | Clinical Chemistry |
| Tobramycin | Tobramycin | Clinical Chemistry |
| Total Protein | Total protein | Clinical Chemistry |
| Triglycerides | Triglycerides | Clinical Chemistry |
| Vancomycin | Vancomycin | Clinical Chemistry |
| Vitamin B12 | Vitamin B12 | Clinical Chemistry |
| Zinc | Zinc | Clinical Chemistry |
| Helicobacter | Helicobacter | Clinical Microbiology |
| MEASUREMENT | Measurement | Electrical |
| Chloride | Chloride | Elemental Analysis |
| MCH | MCH | Elemental Analysis |
| MCHC | MCHC | Elemental Analysis |
| MCV | MCV | Elemental Analysis |
| Potassium | Potassium | Elemental Analysis |
| Sodium | Sodium | Elemental Analysis |
| MICROALBUMIN | Microalbumin | Food Safety Testing |
| Mycobacterium Leprae | Mycobacterium leprae | Food Safety Testing |
| Direct Antiglobulin Test | Direct Antiglobulin Test: detection of | Manual technique using BioRad | Hematology |
| Fibrinogen (Derived) | Fibrinogen (derived) | Hematology |
| Haemoglobin | Haemoglobin | Hematology |
| Hemocue 201DM | Manchester Nova Statstrip 79 | Hemocue 201DM | Hematology |
| Kell | Kell: K | QE-BT-AUT009 | Hematology |
| MNS | MNS: M,N,S,s | BTF-EAL3-10 | Hematology |
| Platelets | Platelets | Hematology |
| Statstrip Statstrip 201DM Hb | Wards | Statstrip Statstrip 201DM Hb | Hematology |
| Thrombophilia Screening: Anti-thrombin 3 activity | Thrombophilia screening: | Chromogenic detection method | Hematology |
| White Blood Cell Count | White Blood Cell Count | Hematology |
| Dendritic cells | Dendritic cells: cortical thymocytes: | CD1a | Histopathology / Cytology |
| Detection of the Following: Acid and Neutral Mucins | Detection of the following: | Special Staining using in house | Histopathology / Cytology |
| Semen Fertility Testing: | 2021) and manual method and | Semen Fertility testing: | Based on WHO laboratory manual | Histopathology / Cytology |
| Semen Post vasectomy: | 2016 Laboratory guidelines for post | Semen Post vasectomy: | Based on 2016 Laboratory | Histopathology / Cytology |
| Volume | Colorimetric strips | Volume | Colorimetric strips | Histopathology / Cytology |
| Volume | Volume/weight | Volume | Volume/weight | Histopathology / Cytology |
| Ab to PR3 | Serum | Ab to PR3 | Immunology / Serology |
| Amyloid | Amyloid | Immunology / Serology |
| Anti B2 Glycoprotein IgG | Serum | Anti B2 Glycoprotein IgG | Immunology / Serology |
| Antibodies | Antibodies: | Adrenal | Immunology / Serology |
| Compatibility Testing | Compatibility Testing: | Manual Biovue crossmatching BTR-S-031 | Immunology / Serology |
| Duffy | Duffy: Fya and Fyb | HAEM-BT-INVGN-014 | Immunology / Serology |
| IGF-BP3 | IGF BP3 | Immunology / Serology |
| Immunochemistry | Immunochemistry | Immunology / Serology |
| Immunotyping | Immunotyping | Immunology / Serology |
| Lewis | Lewis: Lea and Leb | Pathology Partnership | Immunology / Serology |
| Lutheran: Anti-Lu a , Lu b | Lutheran: Lua,Lub | BTF-EAL3-25 | Immunology / Serology |
| Phospho-Tau | Phospho-Tau | Immunology / Serology |
| Rheumatoid Factor | Rheumatoid Factor | Immunology / Serology |
| Screen | screen: | • Human recombinant | Immunology / Serology |
| Total-Tau | Total-TAU | Immunology / Serology |
| Detection of sperm (Azoospermia) | SOP INS/DRM/AND/064 | Detection of sperm (Azoospermia) | SOP INS/DRM/AND/064 | Molecular Diagnostics / PCR |
| Detection of sperm | SOP INS/DRM/AND/028 | Detection of sperm | SOP INS/DRM/AND/028 | Molecular Diagnostics / PCR |
| TPMT | TPMT | Molecular Diagnostics / PCR |
| 17-Hydroxy Progesterone measurement | 17-Hydroxy Progesterone measurement | Other |
| 17-hydroxyprogesterone (17- OHP) | 17-hydroxyprogesterone (17- OHP) | Other |
| 24-hour urine 5-HIAA measurement | 24-hour urine 5-HIAA measurement | Other |
| 24hr Creatinine Clearance | 24hr Creatinine Clearance | Other |
| 24hr urine excretion calculation | 24hr urine excretion calculation | Other |
| 25 hydroxy vitamin D2/D3 | 25 hydroxy vitamin D2/D3 | Other |
| 25-hydroxyvitamin D2 and D3 | 25-hydroxyvitamin D2 and D3 | Other |
| 7-alpha-hydroxy-cholestenone | 7-alpha-hydroxy-cholestenone | Other |
| 79 (Dual) | Hospital Nova Statstrip | 79 (Dual) | Other |
| 79 (Dual) co- oximetry | 79 (Dual) co- oximetry | Other |
| A Rh Negative | A Rh Negative | Other |
| AB Rh D Negative | AB Rh D negative | Other |
| AB Rh D Positive | AB Rh D positive | Other |
| AB Word Lists | AB Word lists | Other |
| AB Wordlists | AB Wordlists | Other |
| AKI | AKI | Other |
| ALK gene rearrangements associated with Analaplastic karge cell lymphoma and inflammatory | ALK gene rearrangements associated with Analaplastic karge cell lymphoma and inflammatory | Other |
| ALK positive non-small cell lung carcinomas | ALK positive non-small cell lung carcinomas | Other |
| APTT | aPTT | Other |
| APTT correction with normal plasma | APTT correction with normal plasma | Other |
| Ab to ENA | Ab to ENA | Other |
| Ab to GBM | Ab to GBM | Other |
| Ab to MPO | Ab to MPO | Other |
| Ab to dsDNA | Ab to dsDNA | Other |
| Acetyl Choline Receptor Abs (ACHR) | Acetyl Choline Receptor Abs (ACHR) | Other |
| Acid & Neutral mucins | Acid & Neutral mucins | Other |
| Acid Fast Bacilli | Acid fast bacilli | Other |
| Acid Mucins | Acid Mucins | Other |
| Acid and neutral mucopolysaccharides | Acid and neutral mucopolysaccharides | Other |
| Acid mucins measurement | Acid mucins measurement | Other |
| Activated Partial | Activated Partial | Other |
| Acute Leukaemia Panel | Acute Leukaemia Panel: | SOP: IMMHI/013, IMMHI/043, | Other |
| Acyl carnitines and free carnitine | Acyl carnitines and free carnitine | Other |
| Adenocarcimoma | Adenocarcimoma | Other |
| Adipose cells | Adipose cells | Other |
| Adrenal, granulosa cells | Adrenal, granulosa cells | Other |
| Adult Hearing Services | Adult Hearing Services: Otoscopy | Other |
| Adults with complex needs rehabilitation | Adults with complex needs rehabilitation | Other |
| Aid in assessment of breast cancer when Herceptin treatment is considered | Aid in assessment of breast cancer when Herceptin treatment is considered | Other |
| Airway Resistance | Airway Resistance | Other |
| Alanine Transaminase (ALT) | Alanine Transaminase (ALT) | Other |
| Aldosterone (D7 Aldosterone Internal Standard) | Aldosterone (D7 Aldosterone Internal Standard) | Other |
| Alkaline Phosphatase iso-enzymes | Alkaline Phosphatase iso-enzymes | Other |
| All epithelial types measurement | All epithelial types measurement | Other |
| Alpha islets of langerhans cells, pancreatic islets | Alpha islets of langerhans cells, pancreatic islets | Other |
| Alpha thalassemia (HBA1 and HBA2) | Alpha thalassemia (HBA1 and HBA2) | Other |
| Alpha/Beta TCR Double | Alpha/Beta TCR Double | Other |
| Alternative Pathway | Alternative Pathway | Other |
| Alveolar Rahbdomyosarcoma | Alveolar Rahbdomyosarcoma | Other |
| Ambulatory Blood Pressure | Ambulatory Blood Pressure | Other |
| Ambulatory ECG Monitoring and Analysis – Adult | Ambulatory ECG Monitoring and Analysis – Adult | Other |
| Ambulatory Oxygen Assessment | Ambulatory Oxygen Assessment | Other |
| Amino acid quantitation | Amino acid quantitation | Other |
| Amplification of the MDM2 gene associated with Lipomatous tumour | Amplification of the MDM2 gene associated with Lipomatous tumour | Other |
| Amplification of the MYC-C gene associated with higher risk medulloblastoma | Amplification of the MYC-C gene associated with higher risk medulloblastoma | Other |
| Amplification of the MYC-N gene associated with higher risk neuroblastoma and medulloblastoma | Amplification of the MYC-N gene associated with higher risk neuroblastoma and medulloblastoma | Other |
| Analysis | Analysis | Other |
| Analysis of copy number changes for the purpose of clinical diagnosis and carrier/predictive testing in genes: Dystrophin, GJB1/PMP22/MPZ, LDLR CFTR SMN1/2 | Analysis of copy number changes for the purpose of clinical diagnosis and carrier/predictive testing in genes: Dystrophin, GJB1/PMP22/MPZ, LDLR CFTR SMN1/2 | Other |
| Anaplastic lymphoma | Anaplastic lymphoma | Other |
| Androgen Profile | Androgen profile: Testosterone | Other |
| Anti B2 Glycoprotein IgM tTG IgA tTG IgG | Anti B2 Glycoprotein IgM tTG IgA tTG IgG | Other |
| Anti CCP Ab | Anti CCP Ab | Other |
| Anti Cardiolipin Ab IgG | Anti Cardiolipin Ab IgG | Other |
| Anti Cardiolipin Ab IgM | Anti Cardiolipin Ab IgM | Other |
| Anti Nuclear antibody | Anti-nuclear antibody | Other |
| Anti Xa levels | Anti-Xa levels | Other |
| Anti-Mitochondria Ab (AMA)** | Anti-Mitochondria Ab (AMA)** | Other |
| Anti-Mullerian Hormone AMH | Anti-Mullerian Hormone AMH | Other |
| Anti-Nuclear Ab (ANA)** | Anti-Nuclear Ab (ANA)** | Other |
| Antibody identification and phenotyping | Antibody identification and phenotyping | Other |
| Antibody panels of the following systems: Rh-hr, KELL, DUFFY, KIDD, LEWIS, MNS, P and LUTHERAN | Antibody panels of the following systems: Rh-hr, KELL, DUFFY, KIDD, LEWIS, MNS, P and LUTHERAN | Other |
| Antihypertensive drug screen – metabolites of Eplerenone Canrenone Amiloride Hydralazine Doxazosin Prazosin Aliskiren Moxonidine Methyldopa | Antihypertensive drug screen – metabolites of Eplerenone Canrenone Amiloride Hydralazine Doxazosin Prazosin Aliskiren Moxonidine Methyldopa | Other |
| Antihypertensive drug screen – metabolites of: Enalapril Enalaprilat Lisinopril Perindopril Perindoprilat Ramipril Ramiprilat Quianpril Quinaprilat Trandolapril Trandolaprilat Candesartan Irbesartan Valsartan Losartan Telmisartan Olmesartan Atenolol Metoprolol Propranolol Labetalol Bisoprolol Nebivolol Amloodipine Delodipine Lercanidipine Lacidipine Diltiazem Verapamil Norverapamil Nifedipine Bendoflumethiazide Hydrochlorothiazide Indapamide Chlorthalidone Bumetanide Furosemide measurement | Antihypertensive drug screen – metabolites of: Enalapril Enalaprilat Lisinopril Perindopril Perindoprilat Ramipril Ramiprilat Quianpril Quinaprilat Trandolapril Trandolaprilat Candesartan Irbesartan Valsartan Losartan Telmisartan Olmesartan Atenolol Metoprolol Propranolol Labetalol Bisoprolol Nebivolol Amloodipine Delodipine Lercanidipine Lacidipine Diltiazem Verapamil Norverapamil Nifedipine Bendoflumethiazide Hydrochlorothiazide Indapamide Chlorthalidone Bumetanide Furosemide measurement | Other |
| Antimicrobial susceptibility testing of moulds | Antimicrobial susceptibility testing of moulds | Other |
| Antimicrobial susceptibility testing of yeasts | Antimicrobial susceptibility testing of yeasts | Other |
| Apocrine breast tumours | Apocrine breast tumours | Other |
| Arylsulphatase A (Metachromatic leukodystrophy) | Arylsulphatase A (Metachromatic leukodystrophy) | Other |
| Arylsulphatase B (MPS VI, Maroteaux-Lamy) | Arylsulphatase B (MPS VI, Maroteaux-Lamy) | Other |
| Asparatate Transaminase (AST) | Asparatate Transaminase (AST) | Other |
| Aspartylglucosaminidase (Aspartylglucosaminuria) | Aspartylglucosaminidase (Aspartylglucosaminuria) | Other |
| Aspergillus fumigatus , A. flavus , A. niger , A. terreus , A. nidulans , A. versicolor , and A. glaucus | Aspergillus fumigatus , A. flavus , A. niger , A. terreus , A. nidulans , A. versicolor , and A. glaucus | Other |
| Assessment | Assessment | Other |
| Assessment for Long Term Oxygen | Assessment for Long Term Oxygen | Other |
| Assessment of Bronchodialator | Assessment of Bronchodialator | Other |
| Associated Antigen 2 (IA-2) | Associated Antigen 2 (IA-2) | Other |
| Astrocytes, glial (brain), demonstrates astrocytes | Astrocytes, glial (brain), demonstrates astrocytes | Other |
| Atypical antibody screen and red blood cell phenotyping by detection of antibodies to: Rh: C, D, E, c, e, f, Cw and V | Atypical antibody screen and red blood cell phenotyping by detection of antibodies to: Rh: C, D, E, c, e, f, Cw and V | Other |
| Audiometry | Audiometry | Other |
| Auditory Brainstem Response – | Auditory Brainstem Response – | Other |
| Autoantibodies (Anti-TPO) | Autoantibodies (Anti-TPO) | Other |
| Autoimmunity | Autoimmunity | Other |
| B Cell Maturation Markers | B Cell Maturation Markers | Other |
| B Cell lymphocyte differentiation | B Cell lymphocyte differentiation | Other |
| B Cells | B-Cells | Other |
| B Cells measurement | B cells measurement | Other |
| B Cells, Reed-Sternberg cells | B Cells, Reed-Sternberg cells | Other |
| B Rh D Positive | B Rh D positive | Other |
| B RhD Negative | B RhD Negative | Other |
| B cell Lymphocytes | B-cell lymphocytes | Other |
| B cells & Interfollicular T cells | B cells & Interfollicular T cells | Other |
| B cells, plasma cells | B cells, plasma cells | Other |
| BASO | BASO | Other |
| BKB Sentences or Other Speech Material | BKB Sentences or Other Speech Material | Other |
| BKB sentences or other speech material AB Wordlists | BKB sentences or other speech material AB Wordlists | Other |
| Bacteria/ Fungi | Bacteria/ Fungi | Other |
| Balance: Otoscopy | Balance: Otoscopy | Other |
| Basal cell epithelium | Basal cell epithelium | Other |
| Basal epithelial cells | Basal epithelial cells | Other |
| Basement Membranes | Basement membranes | Other |
| Basophilic and eosinophilic tissue structures | Basophilic and eosinophilic tissue structures | Other |
| Basophils | Basophils | Other |
| Beta Hydroxybutyrate | Beta-hydroxybutyrate | Other |
| Beta cells islets of langerhans measurement | Beta cells islets of langerhans measurement | Other |
| Beta globin gene cluster deletions | Beta globin gene cluster deletions | Other |
| Beta thalassemia (HBB and HBG2 promoter region) | Beta thalassemia (HBB and HBG2 promoter region) | Other |
| Bethesda assay | Bethesda assay | Other |
| Beutler screening test for classical galactosaemia (galactose-1- phosphate uridyl transferase) | Beutler screening test for classical galactosaemia (galactose-1- phosphate uridyl transferase) | Other |
| Bicarbonate measurement | Bicarbonate measurement | Other |
| Bile Acids | Bile acids | Other |
| Biochemical genetics examination for the purposes of clinical diagnosis | Biochemical genetics examination for the purposes of clinical diagnosis | Other |
| Biochemistry examination activities for the purpose of clinical diagnosis | Biochemistry examination activities for the purpose of clinical diagnosis: Metabolic biochemistry | Other |
| Biochemistry examination activities for the purpose of clinical diagnosis Provision of Point of Care testing related to the following: HbA1c | Biochemistry examination activities for the purpose of clinical diagnosis Provision of Point of Care testing related to the following: HbA1c Siemens DCA Vantage Latex agglutination PO-SOP-7 | Other |
| Biochemistry examination activities for the purpose of clinical diagnosis Provision of Point of Care testing related to the following: Glucose | Biochemistry examination activities for the purpose of clinical diagnosis Provision of Point of Care testing related to the following: Nova Statstrip POCT analyser | Other |
| Biochemistry examination activities for the purpose of clinical diagnosis Quantification of: Alpha-1-Antitrypsin | Biochemistry examination activities for the purpose of clinical diagnosis Quantification of: Glucose | Other |
| Biochemistry examination activities for the purpose of clinical diagnosis Urine calcium/creatinine ratio | Biochemistry examination activities for the purpose of clinical diagnosis Urine calcium/creatinine ratio | Other |
| Biochemistry exmaniation activities for the purposes of clinical diagnosis | Biochemistry exmaniation activities for the purposes of clinical diagnosis | Other |
| Bladder cancers, breast cancer | Bladder cancers, breast cancer | Other |
| Bladder/prostate/renal cancers | Bladder/prostate/renal cancers | Other |
| Blood Gas Analysis - earlobe | Blood Gas Analysis - earlobe | Other |
| Blood Group by detection and identification of antigens: A D Positive | Blood Group by detection and identification of antigens: A Rh D Positive | Other |
| Blood Group, A, B, O and AB groups | Blood Group, A, B, O and AB groups | Other |
| Blood Transfusion examinations for the purposes of clinical diagnosis | Blood Transfusion examinations for the purposes of clinical diagnosis | Other |
| Blood film assessment for detection of abnormal cell types, morphology and numbers | Blood film assessment for detection of abnormal cell types, morphology and numbers | Other |
| Bone Anchored Hearing Aid | Bone Anchored Hearing Aid | Other |
| Bone marrow assessment for detection of abnormal cell types, morphology and numbers measurement | Bone marrow assessment for detection of abnormal cell types, morphology and numbers measurement | Other |
| Brain Natriuretic Peptide (NT- ProBNP) | Brain Natriuretic Peptide (NT- ProBNP) | Other |
| Breast and Ovarian cancer (BRCA1 and 2) | Breast and Ovarian cancer (BRCA1 and 2) | Other |
| Breast and Ovarian cancer (BRCA1 and BRCA2) | Breast and Ovarian cancer (BRCA1 and BRCA2) | Other |
| Breast apocrine tumours /prostate carcinomas | Breast apocrine tumours /prostate carcinomas | Other |
| Broad spectrum epithelial marker | Broad spectrum epithelial marker | Other |
| Bronchial Challenge Testing | Bronchial Challenge Testing | Other |
| Budgie ( Melopsittacus undulatus ) | Budgie ( Melopsittacus undulatus ) | Other |
| Busulphan | Busulphan | Other |
| Busulphan pharmacokinetics | Busulphan pharmacokinetics | Other |
| C Reactive Protein | C-Reactive Protein | Other |
| C1 esterase inhibitor functional activity | C1 esterase inhibitor functional activity | Other |
| CARCINOEMBRYONIC ANTIGEN | Carcinoembryonic antigen | Other |
| CD34 enumeration | CD34 enumeration | Other |
| CH50 measurement | CH50 measurement | Other |
| CKD-EPI Cystatin C | CKD-EPI Cystatin C | Other |
| CMV infected cells | CMV infected cells | Other |
| COL1A1-PDGFB fusions associated with Dermatofibrosarcoma protuberans | COL1A1-PDGFB fusions associated with Dermatofibrosarcoma protuberans | Other |
| COSI | COSI | Other |
| CRT Optimisation | CRT Optimisation | Other |
| CTX | CTX | Other |
| Caeruloplasmin | Caeruloplasmin | Other |
| Calculated Parameters | Calculated Parameters: eGFR | Other |
| Calculated parameter | Calculated parameter | Other |
| Caloric Irrigation Test | Caloric Irrigation Test | Other |
| Calprotectin pH | Calprotectin pH | Other |
| Carbamezapine | Carbamezapine | Other |
| Cardiac Resynchronisation Therapy | Cardiac Resynchronisation Therapy | Other |
| Cardiac Resynchronisation Therapy (CRT-P) Follow-up | Cardiac Resynchronisation Therapy (CRT-P) Follow-up | Other |
| Cardiac Rhythm Management: Pacemaker (Brady) Follow-up | Cardiac Rhythm Management: Pacemaker (Brady) Follow-up | Other |
| Cardiopulmonary Exercise | Cardiopulmonary Exercise: Cardiopulmonary Exercise Test | Other |
| Cardiopulmonary Exercise Test | Cardiopulmonary Exercise Test: Field Walking Tests (6 / 12 minutes) | Other |
| Catecholamines as below: Agilent 1100 UPLC ECD BC-SP-S-049 HMMA HVA BC-SP-S-65 Agilent 7850 ICP-MS | Catecholamines as below: Agilent 1100 UPLC ECD BC-SP-S-049 HMMA HVA BC-SP-S-65 Agilent 7850 ICP-MS | Other |
| Cell culture for cryogenic storage, DNA/RNA extraction, export or immortalisation (lymphoblastoid cell lines) | Cell culture for cryogenic storage, DNA/RNA extraction, export or immortalisation (lymphoblastoid cell lines) | Other |
| Chitotriosidase | Chitotriosidase | Other |
| Chordoma | Chordoma | Other |
| Chromogenic Factor VIII and XIII | Chromogenic Factor VIII and XIII | Other |
| Chromosome 6 monosomy measurement | Chromosome 6 monosomy measurement | Other |
| Chromosome analysis for : Prenatal Diagnosis | Chromosome analysis for: Developmental disorders | Other |
| Chronic Leukaemia Panel | Chronic Leukaemia Panel | Other |
| Circles (TRECs) SCID | Circles (TRECs) SCID | Other |
| Citrate | Citrate | Other |
| Classification of lymphomas / Erythrocytes | Classification of lymphomas / Erythrocytes | Other |
| Clauss Fibrinogen | Clauss Fibrinogen | Other |
| Clear cell renal cell carcinoma | Clear cell renal cell carcinoma | Other |
| Clear cell renal cell carcinomas | Clear cell renal cell carcinomas | Other |
| Coagulation | Coagulation: Prothrombin Time | Other |
| Coagulation Factor Assays: Factor II, V, VII, VIII, IX, X, XI, XII Factor VIII Refacto | Coagulation Factor Assays: Roche Cobas 8100 and Sysmex CS5100i coagulation analyser using immune-turbidometry, chromogenic Factor II, V, VII, VIII, IX, X, XI, and optical absorbance XII LP_HAEM_COAG66 Factor VIII Refacto Chromogenic Factor VIII and LFHAEM_COAG41 XIII LP_HAEM_COAG67 LI_HAEM_COAG89 and LI_HAEM_COAG90 Von Willebrand antigen level LP_HAEM-COAG69 Ristocetin Cofactor level Werfen/IL Accustar using chemiluminescent immunoassay measurement | Other |
| Cochlear Microphonic Testing (CMT) | Cochlear Microphonic Testing (CMT) | Other |
| Collagen Binding For Von | Collagen Binding For Von | Other |
| Colorectal cancer (MLH1 hypermethylation and BRAF codon 600) | Colorectal cancer (MLH1 hypermethylation and BRAF codon 600) | Other |
| Complement AP100 | Complement AP100 | Other |
| Complement Studies: C1 esterase inhibitor | Complement Studies: C1 esterase inhibitor | Other |
| Complement dependent cytotoxicity (CDC) testing for solid organ transplantation through detection of IgG and IgM HLA antibodies to donor lymphocytes | Complement dependent cytotoxicity (CDC) testing for solid organ transplantation through detection of IgG and IgM HLA antibodies to donor lymphocytes | Other |
| Complex Adult Services | Complex Adult Services | Other |
| Complex Adult Services – Tinnitus | Complex Adult Services – Tinnitus: Tinnitus Handicap Inventory | Other |
| Complex Paediatric Audiology | Complex Paediatric Audiology | Other |
| Conjugated/Direct Bilirubin | Conjugated/Direct Bilirubin | Other |
| Connective Tissue | Connective tissue | Other |
| Copy Number Variations (CNVs) | Copy Number Variations (CNVs) | Other |
| Cortical Electrical Response | Cortical Electrical Response | Other |
| Cotinine | Cotinine | Other |
| Covid-19 virus | Covid-19 virus | Other |
| Creat | Creat | Other |
| Creatinine Clearance | Creatinine Clearance | Other |
| Creatinine Kinase | Creatinine Kinase | Other |
| Creatinine measurement | Creatinine measurement | Other |
| Creatinine, Chem8, G3 blood gases, ACT Kaolin | Creatinine, Chem8, G3 blood gases, ACT Kaolin | Other |
| Crithidia Ab** | Crithidia Ab** | Other |
| Crossmatch testing for solid organ transplantation | Crossmatch testing for solid organ transplantation | Other |
| Cryoglobulin Typing | Cryoglobulin Typing | Other |
| Cutaneous T Cell Lymphoma | Cutaneous T Cell Lymphoma | Other |
| Cystic Fibrosis (CFTR) | Cystic Fibrosis (CFTR) | Other |
| Cystine | Cystine | Other |
| Cytogenetics examination for the purposes of clinical diagnosis | Cytogenetics examination for the purposes of clinical diagnosis | Other |
| Cytokeratin marker | Cytokeratin marker | Other |
| Cytopathology examination activities for the purposes of clinical diagnosis | Cytopathology examination activities for the purposes of clinical diagnosis | Other |
| DDIT3 gene rearrangements associated with Myxoid liposarcoma | DDIT3 gene rearrangements associated with Myxoid liposarcoma | Other |
| DNA Extraction - quantitation of genomic DNA | DNA Extraction - quantitation of genomic DNA | Other |
| DNA extraction and quality check for subsequent in house analysis (see below), referral to specialist centres and longterm storage | DNA extraction and quality check for subsequent in house analysis (see below), referral to specialist centres and longterm storage | Other |
| DNA extraction and quantification | DNA extraction and quantification | Other |
| DNA sequence identification of yeasts and moulds | DNA sequence identification of yeasts and moulds | Other |
| Damaged neuronal axons | Damaged neuronal axons | Other |
| Decanoylcarnitine | Decanoylcarnitine | Other |
| Defibrillator (CRT-D) Follow-up | Defibrillator (CRT-D) Follow-up | Other |
| Deletion of the 1p36 region associated with higher risk neuroblastoma | Deletion of the 1p36 region associated with higher risk neuroblastoma | Other |
| Deletion of the SMARCB1 region associated with Rhabdoid tumours | Deletion of the SMARCB1 region associated with Rhabdoid tumours | Other |
| Dendritic cells, cerebral cortex | Dendritic cells, cerebral cortex | Other |
| Detection of Aspergillus galactomannan antigen | Detection of Aspergillus galactomannan antigen | Other |
| Detection of Cryptococcal antigen | Detection of cryptococcal antigen | Other |
| Detection of Crystals measurement | Detection of crystals measurement | Other |
| Detection of F8 intron 1 gene inversion mutation | Detection of F8 intron 1 gene inversion mutation | Other |
| Detection of IgG HLA antibodies to donor T and B lymphocytes | Detection of IgG HLA antibodies to donor T and B lymphocytes | Other |
| Detection of TSH Receptor | Detection of TSH Receptor | Other |
| Detection of clinically relevant pharmacogenetic sequence variants in genes: CYP2C19 | Detection of clinically relevant pharmacogenetic sequence variants in genes: • DPYD • CYP2C19 | Other |
| Detection of fungal (1-3)-B-D glucan | Detection of fungal (1-3)-B-D glucan | Other |
| Detection of haemosiderin measurement | Detection of haemosiderin measurement | Other |
| Detection of mutations | Detection of mutations | Other |
| Detection of other Metabolic disorders: Amino acid screen | Detection of other Metabolic disorders: Amino acid screen | Other |
| Detection of paraneoplastic antibodies (Cv2, PNMA2 (Ma2/Ta), Ri, Yo, Hu, recoverin, SOX1, titin, zic4, GAD65 and Tr (DNER)) | Detection of paraneoplastic antibodies (Cv2, PNMA2 (Ma2/Ta), Ri, Yo, Hu, recoverin, SOX1, titin, zic4, GAD65 and Tr (DNER)) | Other |
| Detection of plasma and white cell lysosomal storage enzymes : b-mannosidase (beta Mannosidosis) a-N-acetylglucosaminidase (MPS III B/ Sanfilippo III B disease) a-galactosidase (Fabry disease) confirmatory | Detection of plasma and white cell lysosomal storage enzymes: Acid esterase (liposomal acid lipase) Wolman Disease/ CESD/ LAL-D a-fucosidase (Fucosidosis) b-galactosidase (GM 1 gangliosidosis/ MPS IV B/ Morquio B/ Galactosialidosis b-glucosidase (Gaucher disease) b-glucuronidase (MPS VII, Sly disease) a-iduronidase (Hurler disease / MPS I/ Scheie disease) a-glucosidase (Pompe) confirmatory Galactocerebrosidase (screen) Krabbe leukodystrophy N-acetyl-a-galactosaminidase (Schindler disease) NCL screen (neuronal ceroid lipofuscinosis/ Batten's) b-hexosaminidase A (Tay-Sachs disease) b-hexosaminidase A & B (Sandhoff's disease) a-mannosidase (alpha Mannosidosis) | Other |
| Detection of sequence variants for the purpose of clinical diagnosis and predictive testing in gene: HFE (haemochromatosis) | Detection of sequence variants for the purpose of clinical diagnosis and predictive testing in gene: • HFE (haemochromatosis) | Other |
| Detection of single nucleotide polymorphism of: Prothrombin G20210A | Detection of single nucleotide polymorphism of: Prothrombin G20210A | Other |
| Detection of stored cholesterol(Niemann-Pick Type C) a-glucosidase CRIM (Pompe) | Detection of stored cholesterol(Niemann-Pick Type C) a-glucosidase CRIM (Pompe) | Other |
| Detection of the following gene mutations: F5 | Detection of the following gene mutations: F5 | Other |
| Detection of triazole resistance in Aspergillus fumigatus using identification of DNA polymorphisms in gene cyp51A | Detection of triazole resistance in Aspergillus fumigatus using identification of DNA polymorphisms in gene cyp51A | Other |
| Detection of whole or partial gene deletions and duplications and probe specific mutations of the following genes/disease regions: Angelman syndrome/ Prader-Willi Syndrome (UBE3A, SNRPN) | Detection of whole or partial gene deletions and duplications and probe specific mutations of the following genes/disease regions: Angelman syndrome/ Prader-Willi Syndrome (UBE3A, SNRPN) | Other |
| Detection of whole or partial gene deletions and duplications: Alpha globin gene cluster deletions | Detection of whole or partial gene deletions and duplications: Alpha globin gene cluster deletions | Other |
| Determination of Her2 gene status | Determination of Her2 gene status | Other |
| Determination of Rhesus and Kell Phenotyping (D, C, E, c, e, C w , K) measurement | Determination of Rhesus and Kell Phenotyping (D, C, E, c, e, C w , K) measurement | Other |
| Determination of blood group (ABO, RhD) and Antibody screening using the following panel: NBS cellstab 2 cell panel (CE) covering D, C, E, c, e, C w , K, k, Kp a , Js a , Fy a , Fy b , Jk b , Le a , Le b , P 1 , M, N, S, s, Kp b , Lu b | Determination of blood group (ABO, RhD) and Antibody screening using the following panel: NBS cellstab 2 cell panel (CE) covering D, C, E, c, e, C w , K, k, Kp a , Js a , Fy a , Fy b , Jk b , Le a , Le b , P 1 , M, N, S, s, Kp b , Lu b | Other |
| Determination of the composition of renal calculi | Determination of the composition of renal calculi | Other |
| Dexamethasone | Dexamethasone | Other |
| Differentiates adenocarcinoma from mesothelioma measurement | Differentiates adenocarcinoma from mesothelioma measurement | Other |
| Differentiates hepatocellular tumours | Differentiates hepatocellular tumours | Other |
| Digestion of glycogen measurement | Digestion of glycogen measurement | Other |
| Digoxin b-Amyloid (1-42) | Digoxin b-Amyloid (1-42) | Other |
| Dilute Russell Viper venom confirmation | Dilute Russell Viper venom confirmation | Other |
| Dilute Russell Viper venom time | Dilute Russell Viper venom time | Other |
| Direct LDL Cholesterol | Direct LDL Cholesterol | Other |
| Direct antiglobulin test for detection of antibody bound red cells measurement | Direct antiglobulin test for detection of antibody bound red cells measurement | Other |
| Dix-Hallpike for BPPV | Dix-Hallpike for BPPV | Other |
| Dopamine/creatinine ratio | Dopamine/creatinine ratio | Other |
| Dosage Analysis by quantitative fluorescent PCR: Rapid Aneuploidy Screening, Spinal | Dosage Analysis by quantitative fluorescent PCR: Rapid Aneuploidy Screening, Spinal | Other |
| EBV infected cells | EBV infected cells | Other |
| ECG Event Monitoring and Analysis | ECG Event Monitoring and Analysis | Other |
| ECG and Blood Pressure | ECG and Blood Pressure | Other |
| EMA Binding Assay | EMA Binding Assay | Other |
| EOS | EOS | Other |
| ETV6 gene rearrangements associated with Infantile fibrosarcoma/CMN and mammary analogue carcinoma | ETV6 gene rearrangements associated with Infantile fibrosarcoma/CMN and mammary analogue carcinoma | Other |
| EWSR1-ERG fusions associated with Ewing's sarcoma/PNET | EWSR1-ERG fusions associated with Ewing's sarcoma/PNET | Other |
| EWSR1-FLI1 fusions associated with Ewing's sarcoma/PNET measurement | EWSR1-FLI1 fusions associated with Ewing's sarcoma/PNET measurement | Other |
| Echocardiograms Contrast | Echocardiograms Contrast | Other |
| Echocardiograms – Stress Echo | Echocardiograms – Stress Echo | Other |
| Elastase | Elastase | Other |
| Elastic/Muscle/Connective tissue | Elastic/Muscle/Connective tissue | Other |
| Electrolytes | Electrolytes: BIO-LP-Cobas8000 | Other |
| Electron Microscopy | Electron Microscopy | Other |
| Embryonal rhabdomyosarcoma | Embryonal rhabdomyosarcoma | Other |
| Embryonal tumour | Embryonal tumour | Other |
| Embryonal, Rhabdomyosarcoma, S | Embryonal, Rhabdomyosarcoma, S | Other |
| Endometrial and prostate cancer | Endometrial and prostate cancer | Other |
| Endomysial Ab (IgA)* measurement | Endomysial Ab (IgA)* measurement | Other |
| Endothelial Cells | Endothelial cells | Other |
| Endothelium, lymphatic, lymphatic endothelium, mesothelioma measurement | Endothelium, lymphatic, lymphatic endothelium, mesothelioma measurement | Other |
| Eosinophils | Eosinophils | Other |
| Epithelial Cells | Epithelial Cells | Other |
| Epithelial and endothelial hepatocytes | Epithelial and endothelial hepatocytes | Other |
| Epithelial cells in various normal tissues | Epithelial cells in various normal tissues | Other |
| Epithelial cells, normal ductal epithelial cells, ductal adenocarcinoma | Epithelial cells, normal ductal epithelial cells, ductal adenocarcinoma | Other |
| Epithelium | Epithelium | Other |
| Epithelium, plasma cells | Epithelium, plasma cells | Other |
| Estimated GFR | Estimated GFR | Other |
| Estimated GFR (children) | Estimated GFR (children) | Other |
| Estimation of Erythrocyte | Estimation of Erythrocyte | Other |
| Estimation of Fetomaternal | Estimation of Fetomaternal | Other |
| Evoked /Distortion Product | Evoked /Distortion Product | Other |
| Ewing's / PNET | Ewing's / PNET | Other |
| Examination of cellular material in order to identify or exclude morphological and cytological abnormalities | Examination of cellular material in order to identify or exclude morphological and cytological abnormalities | Other |
| Examination of cellular material to identify or exclude morphological and cytological abnormalities measurement | Examination of cellular material to identify or exclude morphological and cytological abnormalities measurement | Other |
| Examination of tissues to identify or exclude ultrastructural morphological abnormalities for diagnosis | Examination of tissues to identify or exclude ultrastructural morphological abnormalities for diagnosis | Other |
| Examination of tissues to identify or exclude ultrastructural morphological abnormalities for diagnosis measurement | Examination of tissues to identify or exclude ultrastructural morphological abnormalities for diagnosis measurement | Other |
| Exercise Tolerance Testing | Exercise Tolerance Testing | Other |
| Exercise induced asthma studies | Exercise induced asthma studies | Other |
| FIX | FIX | Other |
| FOXO1 gene rearrangements associated with Alveolar Rhabdomyosarcoma | FOXO1 gene rearrangements associated with Alveolar Rhabdomyosarcoma | Other |
| FOXO1-PAX3 fusions associated with Alveolar | FOXO1-PAX3 fusions associated with Alveolar | Other |
| FOXO1-PAX7 fusions associated with Alveolar | FOXO1-PAX7 fusions associated with Alveolar | Other |
| FUS gene rearrangements associated with a variety of different tumours | FUS gene rearrangements associated with a variety of different tumours | Other |
| FV Leiden | FV Leiden | Other |
| FV, FII, FVII, FX | FV, FII, FVII, FX | Other |
| FVIII | FVIII | Other |
| FVIII, FIX, FXI, FXII measurement | FVIII, FIX, FXI, FXII measurement | Other |
| Factor VIII, IX, XI | Factor VIII, IX, XI | Other |
| Factors Assays | Factors Assays | Other |
| Faecal immunochemical testing (FIT) measurement | Faecal immunochemical testing (FIT) measurement | Other |
| Familial Adenomatous Polyposis (APC) (FAP) and MUTYH- Associated Polyposis (MUTYH) (MAP) | Familial Adenomatous Polyposis (APC) (FAP) and MUTYH- Associated Polyposis (MUTYH) (MAP) | Other |
| Fat laden and hemosiderin laden macrophages | Fat laden and hemosiderin laden macrophages | Other |
| Field walking tests (shuttle walk tests) | Field walking tests (shuttle walk tests) | Other |
| Fluorescent detection of Fibrinogen | Fluorescent detection of Fibrinogen | Other |
| Fluorescent detection of IgA | Fluorescent detection of IgA | Other |
| Fluorescent detection of IgG | Fluorescent detection of IgG | Other |
| Fluorescent detection of Kappa light chains | Fluorescent detection of Kappa light chains | Other |
| Fluorescent detection of Lambda light chains | Fluorescent detection of Lambda light chains | Other |
| Fluorescent detection of complement C1Q | Fluorescent detection of complement C1Q | Other |
| Fluorescent detection of complement C3 | Fluorescent detection of complement C3 | Other |
| Folicle Stimulating Hormone (FSH) | Folicle Stimulating Hormone (FSH) | Other |
| Follicular Dendritic Cells | Follicular Dendritic cells | Other |
| Follicular dendritic cells, B cells, some T cells | Follicular dendritic cells, B cells, some T cells | Other |
| Follow-up | Follow-up | Other |
| Four Cell Anti-D Screening | Four Cell Anti-D Screening | Other |
| Fraction exhaled nitric oxide (FeNO) | Fraction exhaled nitric oxide (FeNO) | Other |
| Fragile X Syndrome and associated disorders (FXTAS and FXPOI) (FMR1) | Fragile X Syndrome and associated disorders (FXTAS and FXPOI) (FMR1) | Other |
| Free Androgen Index | Free Androgen Index | Other |
| Free Androgen Index measurement | Free Androgen Index measurement | Other |
| Free Cortisol | Free Cortisol | Other |
| Free Fatty Acids | Free Fatty Acids | Other |
| Free Protein S level | Free Protein S level | Other |
| Full Blood Count | Full Blood Count: White blood cells, neutrophils, lymphocytes, eosinophils, monocytes, basophils, nucleated red blood cells, reticulocytes | Other |
| Fungi (Aspergillus and Pneumocystis) | Fungi (Aspergillus and Pneumocystis) | Other |
| Fungi/Glycogen/Mucins | Fungi/Glycogen/Mucins | Other |
| G6PD screen and assay | G6PD screen and assay | Other |
| GAAD score (using patients’ gender, age, AFP and PIVKA) | GAAD score (using patients’ gender, age, AFP and PIVKA) | Other |
| GI tract epithelium, fibromatosis, epithelium | GI tract epithelium, fibromatosis, epithelium | Other |
| GI tract epithelium, papillary thyroid carcinoma | GI tract epithelium, papillary thyroid carcinoma | Other |
| GIST TUMOURS | GIST tumours | Other |
| Gastric Parietal Cell Ab (GPC) | Gastric Parietal Cell Ab (GPC) | Other |
| Gem | Gem | Other |
| Germ Cell Tumours | Germ cell tumours | Other |
| Germ cells, placenta | Germ cells, placenta | Other |
| Germinal centre B cells | Germinal centre B cells | Other |
| Glial cells | Glial cells | Other |
| Glioma (KIAA1549: BRAF fusion, C11orf95: RELA fusion, EGFRvIII transcript) | RNA from FFPE samples Glioma (KIAA1549: BRAF fusion, | DOC4253, DOC4344^, DOC4206 | Other |
| Glioma (MGMT hypermethylation and BRAF codon 600) | Glioma (MGMT hypermethylation and BRAF codon 600) | Other |
| Glucose Gem 5000 | Glucose Gem 5000 | Other |
| Glucose Glucose/Ketone | Glucose Glucose/Ketone | Other |
| Glucose Ketone Haemoglobin | Glucose Ketone Haemoglobin | Other |
| Glucose/Ketone Blood Abbot | Glucose/Ketone Blood Abbot | Other |
| Glucose/Ketone Urinalysis | Glucose/Ketone Urinalysis | Other |
| Glutamic Acid Decarboxylase (GAD) Abs | Glutamic Acid Decarboxylase (GAD) Abs | Other |
| Glutarylcarnitine | Glutarylcarnitine | Other |
| Glycated Haemoglobin | Glycated Haemoglobin | Other |
| Glycogen storage disease | Glycogen storage disease | Other |
| Gonadotrophin (Beta hCG) measurement | Gonadotrophin (Beta hCG) measurement | Other |
| Graft v Host determination following bone marrow transplant | Graft v Host determination following bone marrow transplant | Other |
| Gram positive and Gram- negative bacteria | Gram positive and Gram- negative bacteria | Other |
| Granulocytes Reed-Sternberg cells measurement | Granulocytes Reed-Sternberg cells measurement | Other |
| Growth Hormone | Growth Hormone | Other |
| HB | Hb | Other |
| HCT | HCT | Other |
| HFE C282Y/H63D | HFE C282Y/H63D | Other |
| HGB | HGB | Other |
| HLA-A, B, C, DRB1, DRB3/4/5, DQB1, DQA1, DPB1 and DPA1 to the level of resolution (2nd field) | HLA-A, B, C, DRB1, DRB3/4/5, DQB1, DQA1, DPB1 and DPA1 to the level of resolution (2nd field) | Other |
| HPV Marker | HPV marker | Other |
| HSV-1 infected cells | HSV-1 infected cells | Other |
| HVA | HVA | Other |
| Haematocrit | Haematocrit | Other |
| Haematological/Oncology disorders | Haematological/Oncology disorders | Other |
| Haematology examinations for the purposes of clinical diagnosis | Haematology examinations for the purposes of clinical diagnosis | Other |
| Haematology examinations for the purposes of clinical diagnosis | Haematology examinations for the purposes of clinical diagnosis | Other |
| Haematology examinations for the purposes of clinical diagnosis Coagulation examination activities for the purpose of clinical diagnosis | Haematology examinations for the purposes of clinical diagnosis Coagulation examination activities for the purpose of clinical diagnosis | Other |
| Haematology examinations for the purposes of clinical diagnosis WBC | Haematology examinations for the purposes of clinical diagnosis WBC | Other |
| Haematopoietic cells | Haematopoietic cells | Other |
| Haemoglobin pH, pCO 2 and pO 2 | Haemoglobin pH, pCO 2 and pO 2 | Other |
| Haemoglobin, reduced haemoglobin | Haemoglobin, reduced haemoglobin | Other |
| Haemoglobinopathy | Haemoglobinopathy | Other |
| Haemopoetic Progenitor Stem cell | Haemopoetic Progenitor Stem cell | Other |
| Haemorrhage (FMH), detection of HbF in maternal sample | Haemorrhage (FMH), detection of HbF in maternal sample | Other |
| Haemosiderin and ferric acid | Haemosiderin and ferric acid | Other |
| Hairy Cell Leukaemia | Hairy cell leukaemia | Other |
| Hearing Aid Diagnostics and Adjustment | Hearing Aid Diagnostics and Adjustment | Other |
| Hearing Aid Diagnostics and Adjustments | Hearing Aid Diagnostics and Adjustments | Other |
| Hearing Aid Fitting | Hearing Aid Fitting | Other |
| Helicobacter Pylorii infected gastric ducts & crypt measurement | Helicobacter Pylorii infected gastric ducts & crypt measurement | Other |
| Helicobacter/Microorganisms | Helicobacter/microorganisms | Other |
| Helper T Cells | Helper T cells | Other |
| Heparan sulphamidase (MPS III A, Sanfilippo A) | Heparan sulphamidase (MPS III A, Sanfilippo A) | Other |
| Heparin Induced | Heparin Induced | Other |
| Hepatitis B surface antigen, copper associated protein | Hepatitis B surface antigen, copper associated protein | Other |
| Hepatocellular carcinomas | Hepatocellular carcinomas | Other |
| Hepatocytes | Hepatocytes | Other |
| Hepatocytes/ choroid lesions | Hepatocytes/ choroid lesions | Other |
| Herpes virus, Kaposi’s sarcoma | Herpes virus, Kaposi’s sarcoma | Other |
| High Density Cholesterol | High Density Cholesterol | Other |
| High Frequency Probe Tone | High Frequency Probe Tone | Other |
| High Frequency Pure Tone | High Frequency Pure Tone | Other |
| High sensitivity oestradiol | High sensitivity oestradiol | Other |
| Histiocytes, dermatofibroma | Histiocytes, dermatofibroma | Other |
| Histiocytes, granulocytes and monocytes | Histiocytes, granulocytes and monocytes | Other |
| Histochemistry for the identification of the following | Histochemistry for the identification of the following | Other |
| Histochemistry for the identification of the following measurement | Histochemistry for the identification of the following measurement | Other |
| Histocompatibility Examinations | Histocompatibility Examinations | Other |
| Histocytes, monocytes and macrophages in spleen and peripheral bolld | Histocytes, monocytes and macrophages in spleen and peripheral bolld | Other |
| Histone 3 trimethylated on lysine 27 | Histone 3 trimethylated on lysine 27 | Other |
| Histopathology | Histopathology | Other |
| History Taking | History Taking | Other |
| Home Monitoring/Remote Device | Home Monitoring/Remote Device | Other |
| Human Chorionic | Human Chorionic | Other |
| Human Leucocyte Antigen (HLA) | Human Leucocyte Antigen (HLA) | Other |
| Hyaluronic Acid | Hyaluronic acid | Other |
| Hypercusis Questionnaire | Hypercusis Questionnaire | Other |
| Hypoxic Challenge Test | Hypoxic Challenge Test | Other |
| ID Panel (T & B) Lymphocytes | ID Panel (T & B) Lymphocytes | Other |
| IGA | IgA | Other |
| IGG | IgG | Other |
| IGM | IgM | Other |
| INR measurement | INR measurement | Other |
| Identification of mould isolates of clinical significance | Identification of mould isolates of clinical significance | Other |
| Identification of moulds of clinical significance | Identification of moulds of clinical significance | Other |
| Identification of yeasts of clinical significance | Identification of yeasts of clinical significance | Other |
| Identity testing | Identity testing | Other |
| Iduronate sulphatase (Hunter disease/ MPS II) a-galactosidase (Fabry disease) screen a-glucosidase (Pompe) screen | Iduronate sulphatase (Hunter disease/ MPS II) a-galactosidase (Fabry disease) screen a-glucosidase (Pompe) screen | Other |
| IgA immunoglobulins | IgA immunoglobulins | Other |
| IgD immunoglobulins | IgD immunoglobulins | Other |
| IgG Subclasses | IgG Subclasses | Other |
| IgG immunoglobulins | IgG immunoglobulins | Other |
| IgG to following: Aspergillus fumigatus | IgG to following: Aspergillus fumigatus | Other |
| IgM immunoglobulins | IgM immunoglobulins | Other |
| Immune Monitoring (CD3, CD4, CD8, CD16+56, CD19, CD35 counts) measurement | Immune Monitoring (CD3, CD4, CD8, CD16+56, CD19, CD35 counts) measurement | Other |
| Immuno-deficiency and haematological malignancy | Immuno-deficiency and haematological malignancy | Other |
| Immuno-reactive trypsin measurement | Immuno-reactive trypsin measurement | Other |
| Immunofixation | Immunofixation | Other |
| Immunogenetics Examinations | Immunogenetics Examinations | Other |
| Immunoglobulins | Immunoglobulins | Other |
| Immunoglobulins measurement | Immunoglobulins measurement | Other |
| Immunological examinations for the purpose of clinical diagnosis | Immunological examinations for the purpose of clinical diagnosis | Other |
| Immunological examinations for the purpose of clinical diagnosis Detection of: Adalimumab drug and antibody levels | Immunological examinations for the purpose of clinical diagnosis Detection of: Adalimumab drug and antibody levels | Other |
| Implantable defibrillator (ICD) | Implantable defibrillator (ICD) | Other |
| Impression Taking | Impression Taking | Other |
| Indels | Indels | Other |
| Inflammatory Myopathies | Inflammatory Myopathies | Other |
| Inflammatory Myopathies measurement | Inflammatory Myopathies measurement | Other |
| Infliximab drug and antibody levels | Infliximab drug and antibody levels | Other |
| Inhibitor assays: Nijmegan modification | Inhibitor assays: Semi-automated technique with manual initial set up and automated Nijmegan modification Roche Cobas 8100 and Sysmex Bethesda assay CS5100i coagulation analyser using • FVIII immuno-turbidimetry, chromogenic • FIX and optical absorbance and chromogenic methods LP_HAEM_COAG63 LI_HAEM_COAG88 Monitoring of Factor replacement Therapies One stage clotting assay FVIII Emicizumab-modified FVIII assay(standard human plasma for calibration curve replaced by Emicizumab LP_HAEM-COAG64 Factors Assays FV, FII, FVII, FX Dade Innovin PT reagent LP_HAEM_COAG66 FVIII, FIX, FXI, FXII Actin FS – APTT reagent LP_HAEM_COAG66 CaCl2 LP_HAEM_COAG66 measurement | Other |
| Insulin (Ultrasensitive) | Insulin (Ultrasensitive) | Other |
| Insulin (normal) | Insulin (normal) | Other |
| Insulin to C peptide ratio | Insulin to C peptide ratio | Other |
| Interferon gamma release assay (IGRA) | Interferon gamma release assay (IGRA) | Other |
| Interpretation and reporting of HPV DNA results measurement | Interpretation and reporting of HPV DNA results measurement | Other |
| Interventions | Interventions: Assessment of Bronchodilator | Other |
| Intestinal epithelium, Adenocarcinoma and carcinoid (intestinal epithelium) | Intestinal epithelium, Adenocarcinoma and carcinoid (intestinal epithelium) | Other |
| Iron stain | Iron stain | Other |
| Isavuconazole | Isavuconazole | Other |
| Isavuconazole measurement | Isavuconazole measurement | Other |
| Isolation and characterisation of yeasts and moulds of clinical significance | Isolation and characterisation of yeasts and moulds of clinical significance | Other |
| Isovalerylcarnitine | Isovalerylcarnitine | Other |
| Itraconazole | Itraconazole | Other |
| Ketones | Ketones | Other |
| Kidd | Kidd: Jka,Jkb | Gel-based microtyping system, | Other |
| L Selectin Shedding Assay | L Selectin Shedding Assay | Other |
| LAD Markers | LAD Markers | Other |
| LYMPH | LYMPH | Other |
| Lactate DeHydrogenase | Lactate Dehydrogenase | Other |
| Lambda Light Chains | Lambda light chains | Other |
| Langerhans cells | Langerhans cells | Other |
| Langerhans/ dendritic cells | Langerhans/ dendritic cells | Other |
| Leucine | Leucine | Other |
| Lipid storage Disease | Lipid storage Disease | Other |
| Liver Kidney Microsomal Ab (LKM)** | Liver Kidney Microsomal Ab (LKM)** | Other |
| Low Molecular Weight Heparin | Low molecular weight heparin | Other |
| Lung Adenocarcinoma | Lung adenocarcinoma | Other |
| Lung Mechanics : Spirometry / Flow Volume Loops | Lung Mechanics: Spirometry | Other |
| Lung, bladder, prostate carcinomas | Lung, bladder, prostate carcinomas | Other |
| Lupus anticoagulant testing: APTT | Lupus anticoagulant testing: Roche Cobas 8100 and Sysmex APTT CS5100i coagulation analyser using Dilute Russell Viper venom immuno-turbidimetry, chromogenic time and optical absorbance Dilute Russell Viper venom LP_HAEM_COAG65 confirmation Anti Xa levels LP_HAEM_COAG61 Von Willebrands factor antigen LP_HAEM_COAG69 | Other |
| Lymphoblasts, cortical thymocytes, lymphoblastic leukaemia | Lymphoblasts, cortical thymocytes, lymphoblastic leukaemia | Other |
| Lymphocytes | Lymphocytes | Other |
| Lynch Syndrome (HNPCC, familial colorectal cancer) (MLH1, MSH2, MSH6) | Lynch Syndrome (HNPCC, familial colorectal cancer) (MLH1, MSH2, MSH6) | Other |
| Lysosyme activity | Lysosyme activity | Other |
| MCADD common mutation (ACADM) | MCADD common mutation (ACADM) | Other |
| MGMT methylation analysis (Giloma) | MGMT methylation analysis (Giloma) | Other |
| MLH1 promoter hypermethylation (MLH1) | MLH1 promoter hypermethylation (MLH1) | Other |
| MMR testing for Lynch syndrome | MMR testing for Lynch syndrome | Other |
| MONO | MONO | Other |
| MacroProlactin | Macroprolactin | Other |
| Macrophages | Macrophages | Other |
| Macroprolactin measurement | Macroprolactin measurement | Other |
| Malaria screen for P. falciparum | Malaria screen for P. falciparum | Other |
| Manchester Picture Test | Manchester Picture Test | Other |
| Manchester University NHS Foundation Trust | Manchester University NHS Foundation Trust | Other |
| Mantle Cell lymphoma, Expressed in variety of tumours | Mantle Cell lymphoma, Expressed in variety of tumours | Other |
| Mast Cell Tryptase | Mast cell tryptase | Other |
| Mast Cells | Mast Cells | Other |
| Mast cells, GIST tumours | Mast cells, GIST tumours | Other |
| Maternal contamination testing | Maternal contamination testing | Other |
| McCardles disease | McCardles disease | Other |
| McCormick Toy Test | McCormick Toy Test | Other |
| Mean Cell Haemoglobin | Mean Cell Haemoglobin | Other |
| Mean Cell Haemoglobin concentration | Mean cell haemoglobin concentration | Other |
| Mean Cell Volume | Mean cell volume | Other |
| Mean Platelet volume | Mean Platelet volume | Other |
| Measurement of Insulinoma | Measurement of Insulinoma | Other |
| Measurement of Zinc | Measurement of Zinc | Other |
| Measurements | Measurements | Other |
| Medullary Thyroid Tumours | Medullary Thyroid Tumours | Other |
| Megakaryocytes | Megakaryocytes | Other |
| Melanin | Melanin | Other |
| Melanocytes | Melanocytes | Other |
| Melanocytes and myoepithelial cells, melanoma | Melanocytes and myoepithelial cells, melanoma | Other |
| Melanocytes, Melanoma | Melanocytes, melanoma | Other |
| Melanocytes, nerve cells | Melanocytes, nerve cells | Other |
| Melanocytic cells | Melanocytic cells | Other |
| Membrane attack complexes | Membrane attack complexes | Other |
| Membranous Proteins | Membranous Proteins | Other |
| Membranous Proteins measurement | Membranous Proteins measurement | Other |
| Meningiomas (SMARCE1) | Meningiomas (SMARCE1) | Other |
| Mesothelia, nerves | Mesothelia, nerves | Other |
| Metabolic Exercise Testing/Cardio- Respiratory Exercise Testing Tilt Testing and Autonomic Function Echocardiography: Echocardiograms TTE – Adult | Metabolic Exercise Testing/Cardio- Respiratory Exercise Testing Tilt Testing and Autonomic Function Echocardiography: Echocardiograms TTE – Adult | Other |
| Metanephrines | Metanephrines | Other |
| Methionine | Methionine | Other |
| Methotrexate | Methotrexate | Other |
| Methylmercaptopurine nucleotides (6MMPN) | Methylmercaptopurine nucleotides (6MMPN) | Other |
| Microalbumin/Creatinine Ratio | Microalbumin/creatinine ratio | Other |
| Micropolysporia faeni | Micropolysporia faeni | Other |
| Mitochondrial abnormalities | Mitochondrial abnormalities | Other |
| Mitochondrial abnormalities / SDH activity | Mitochondrial abnormalities / SDH activity | Other |
| Molar Pregancy | Molar Pregancy | Other |
| Molecular Haematology examinations for the purposes of clinical diagnosis | Molecular Haematology examinations for the purposes of clinical diagnosis | Other |
| Molecular Oncology examinations for the purposes of clinical diagnosis | Molecular Oncology examinations for the purposes of clinical diagnosis | Other |
| Molecular and Cytogenetics examination activities for the purposes of clinical diagnosis: Chromosome profile analysis for detection of chromosomal imbalance as copy number gains or losses, and copy neutral changes | Molecular and Cytogenetics examination activities for the purposes of clinical diagnosis: Cytogenetics | Other |
| Molecular detection of Aspergillus spp. genomic DNA which includes | Molecular detection of Aspergillus spp. genomic DNA which includes | Other |
| Molecular detection of: EWSR1 gene rearrangements associated with a variety of different tumours | Molecular detection of: measurement | Other |
| Molecular genetics examination for the purposes of clinical diagnosis | Molecular genetics examination for the purposes of clinical diagnosis | Other |
| Monitoring | Monitoring | Other |
| Monitoring - reported as % donor engraftment | Monitoring - reported as % donor engraftment | Other |
| Monitoring Analysis | Monitoring Analysis | Other |
| Monitoring of Factor replacement Therapies | Monitoring of Factor replacement Therapies | Other |
| Monitoring/Antibiotic | Monitoring/Antibiotic | Other |
| Monocytes | Monocytes | Other |
| Morphological Assessment and Interpretation/Diagnosis | Morphological assessment and interpretation/diagnosis | Other |
| Morphological and cytological abnormalities measurement | Morphological and cytological abnormalities measurement | Other |
| Mucopolysaccharide urine screen | Mucopolysaccharide urine screen | Other |
| Multiple hydrolases (I-cell disease/ mucolipidosis II/III) screen. [battery composition depends on sample type] | Multiple hydrolases (I-cell disease/ mucolipidosis II/III) screen. [battery composition depends on sample type] | Other |
| Multiple sulphatases (multiple sulphatase deficiency) [composition can comprise any of several sulphatases] | Multiple sulphatases (multiple sulphatase deficiency) [composition can comprise any of several sulphatases] | Other |
| Muscle Fibre Typing | Muscle Fibre Typing | Other |
| Muscle IHC for the identification of Membranous Proteins | Muscle IHC for the identification of Membranous Proteins | Other |
| Muscle Tinctorial / special stains for the identification of Tissue morphology | Muscle Tinctorial / special stains for the identification of Tissue morphology | Other |
| Muscular Atrophy | Muscular Atrophy | Other |
| Mutation detection for the purpose of clinical diagnosis, carrier detection and predictive testing in genes: Friedreich Ataxia, Myotonic Dystrophy1, Myotonic Dystrophy2 | Mutation detection for the purpose of clinical diagnosis, carrier detection and predictive testing in genes: Friedreich Ataxia, Myotonic Dystrophy1, Myotonic Dystrophy2 | Other |
| Mutation detection for the purpose of clinical diagnosis, carrier detection and predictive testing in the following: Angelman Syndrome/ Prader-Willi Syndrome (UBE3A, SNRPN) | Mutation detection for the purpose of clinical diagnosis, carrier detection and predictive testing in the following: Angelman Syndrome/ Prader-Willi Syndrome (UBE3A, SNRPN) | Other |
| Mutation detection for the purpose of clinical diagnosis, confirmation, carrier detection and predictive testing in C9orf72-related disorders | Mutation detection for the purpose of clinical diagnosis, confirmation, carrier detection and predictive testing in C9orf72-related disorders | Other |
| Mutation detection for the purpose of clinical diagnosis, confirmation, carrier detection and predictive testing in disorders: Huntington Disease, Huntington Disease-like 2 Myotonic Dystrophy1, Myotonic Dystrophy2, Friedreich Ataxia, Oculopharyngeal Muscular Dystrophy, Spinal Bulbar Muscular Atrophy, Spinal Cerebellar Ataxia 1, 2, 3, 6, 7, 12 & 17, Dentatorubral-pallidoluysian atrophy, Maternal Cell Contamination | Mutation detection for the purpose of clinical diagnosis, confirmation, carrier detection and predictive testing in disorders: Huntington Disease, Huntington Disease-like 2 Myotonic Dystrophy1, Myotonic Dystrophy2, Friedreich Ataxia, Oculopharyngeal Muscular Dystrophy, Spinal Bulbar Muscular Atrophy, Spinal Cerebellar Ataxia 1, 2, 3, 6, 7, 12 & 17, Dentatorubral-pallidoluysian atrophy, Maternal Cell Contamination | Other |
| Mutation detection of sequence variants causing genetic diseases and disorder: Single Nucleotide Variants (SNVs) | Mutation detection of sequence variants causing genetic diseases and disorder: Single Nucleotide Variants (SNVs) | Other |
| Mutation detection of sequence variants for the purpose of clinical diagnosis and quality assessment of PCR products: GJB6 (Connexin 30) | Mutation detection of sequence variants for the purpose of clinical diagnosis and quality assessment of PCR products: GJB6 (Connexin 30) | Other |
| Mutation detection, confirmation and carrier testing in disorders/ genes: Allele Specific PCR: Cystic Fibrosis | Mutation detection, confirmation and carrier testing in disorders/ genes: Allele Specific PCR: Cystic Fibrosis | Other |
| Mutation detection, confirmation and carrier/ predictive testing for the purpose of clinical diagnosis in genes: Detection of clinical relevant nucleic acid sequence for confirmation/cascade testing of NGS results or family studies related to validated methods ABCD1 (Adrenoleukodystrophy) Notch3 (Cadasil) LDLR/ APOB ex27/ PCSK9 ex7 (Familial Hypercholesterolaemia) FXN (Friedreich Ataxia) GJB2 (Hearing Loss) PMP22/MPZ/GJB1/MFN2 (HMSN/HNPP) PLA2G6 (Infantile Neuroaxonal Dystrophy) SGCE (Myoclonic Dystonia) MTM1 (Myotubular Myopathy) PANK2 (Pantothenate kinase- associated neurodegeneration) MECP2 (Rett Syndrome) FGFR3 exon 9 and 12 (Achondroplasia and Hypochondroplasia) CFTR (Cystic fibrosis transmembrane conductance regulator) | Mutation detection, confirmation and carrier/ predictive testing for the purpose of clinical diagnosis in genes: Detection of clinical relevant nucleic acid sequence for confirmation/cascade testing of NGS results or family studies related to validated methods ABCD1 (Adrenoleukodystrophy) Notch3 (Cadasil) LDLR/ APOB ex27/ PCSK9 ex7 (Familial Hypercholesterolaemia) FXN (Friedreich Ataxia) GJB2 (Hearing Loss) PMP22/MPZ/GJB1/MFN2 (HMSN/HNPP) PLA2G6 (Infantile Neuroaxonal Dystrophy) SGCE (Myoclonic Dystonia) MTM1 (Myotubular Myopathy) PANK2 (Pantothenate kinase- associated neurodegeneration) MECP2 (Rett Syndrome) FGFR3 exon 9 and 12 (Achondroplasia and Hypochondroplasia) CFTR (Cystic fibrosis transmembrane conductance regulator) | Other |
| Mycology examinations for the purposes of clinical diagnosis | Mycology examinations for the purposes of clinical diagnosis | Other |
| Myelin measurement | Myelin measurement | Other |
| Myelin of the central and peripheral nervous systems | Myelin of the central and peripheral nervous systems | Other |
| Myeloid Cells | Myeloid cells | Other |
| Myeloid cells, leukaemia, melanoma marker | Myeloid cells, leukaemia, melanoma marker | Other |
| N-Terminal of the Prohormone | N-Terminal of the Prohormone | Other |
| NEUT | NEUT | Other |
| NK Cells | NK cells | Other |
| NSCLC companion diagnostic | NSCLC companion diagnostic | Other |
| Natural killer T cells | Natural killer T cells | Other |
| Naïve, Memory & Effector T cells | Naïve, Memory & Effector T cells | Other |
| Negative T Cell (DNT) | Negative T Cell (DNT) | Other |
| Neoplastic liver diseases, yolk sac tumours and mixed germ cell tumours | Neoplastic liver diseases, yolk sac tumours and mixed germ cell tumours | Other |
| Neuroblastoma | Neuroblastoma | Other |
| Neuroendocrine cells for interstitial lung disease | Neuroendocrine cells for interstitial lung disease | Other |
| Neurofibromatosis type 1 (NF1) | Neurofibromatosis type 1 (NF1) | Other |
| Neurofibromatosis type 2 (NF2) | Neurofibromatosis type 2 (NF2) | Other |
| Neurofibromatosis type 2 (NF2; incl. LOH) | Neurofibromatosis type 2 (NF2; incl. LOH) | Other |
| Neurofilaments, neurons | Neurofilaments, neurons | Other |
| Neurons | Neurons | Other |
| Neurons neuroendocrine measurement | Neurons neuroendocrine measurement | Other |
| Neurons, glia, schwann, Nk, T cells, neuroendocrine tumour measurement | Neurons, glia, schwann, Nk, T cells, neuroendocrine tumour measurement | Other |
| Neutral Mucin | Neutral mucin | Other |
| Neutral Mucopolysaccharides, glycogen and fungus | Neutral Mucopolysaccharides, glycogen and fungus | Other |
| Neutrophil Function (DHR) | Neutrophil Function (DHR) | Other |
| Neutrophils | Neutrophils | Other |
| New Born Screening | New Born Screening | Other |
| Newborn Screening (IMD): C5 isobars | Newborn Screening (IMD): Phenylalanine | Other |
| Nova | Nova | Other |
| Nova Nova | Nova Nova | Other |
| Nova Nova Statstrip | Nova Nova Statstrip | Other |
| Nova Statstrip | Nova Statstrip | Other |
| Nova Statstrip Siemens Clinitek | Nova Statstrip Siemens Clinitek | Other |
| Nova Statstrip gases, iSTAT | Nova Statstrip gases, iSTAT | Other |
| Novel Anticoagulant levels: Dabigatran | Novel Anticoagulant levels: Roche Cobas 8100 and Sysmex Dabigatran CS5100i coagulation analyser using Rivoroxaban immuno-turbidimetry, chromogenic Apixaban and optical absorbance Edoxaban LI_HAEM_COAG85 Fondaparinux | Other |
| Nucleated Red Blood cells (not XN450) Reticulocyte count measurement | Nucleated Red Blood cells (not XN450) Reticulocyte count measurement | Other |
| Nucleated red blood cell (NRBC) count | Nucleated red blood cell (NRBC) count | Other |
| O Rh D Negative measurement | O Rh D Negative measurement | Other |
| O Rh D Positive | O Rh D positive | Other |
| OESTROGEN RECEPTOR | Oestrogen receptor | Other |
| Octanoylcarnitine | Octanoylcarnitine | Other |
| Oligosaccharide/ sialic acid screen | Oligosaccharide/ sialic acid screen | Other |
| Orosomucoid | Orosomucoid | Other |
| Otoacoustic Emissions Tests – | Otoacoustic Emissions Tests – | Other |
| Otoacoustic Emissions Tests- Manual/Screening Transient | Otoacoustic Emissions Tests- Manual/Screening Transient | Other |
| Otoacoustic Emissions Tests- Manual/screening Transient Evoked /Distortion Product | Otoacoustic Emissions Tests- Manual/screening Transient Evoked /Distortion Product | Other |
| Overexpression of BCOR in small round, spindle cell or undifferentiated sarcomas | Overexpression of BCOR in small round, spindle cell or undifferentiated sarcomas | Other |
| Oxysterol | Oxysterol | Other |
| P. Malariae | P. malariae | Other |
| P. Ovale | P. ovale | Other |
| P. Vivax | P. vivax | Other |
| P. knowlesi measurement | P. knowlesi measurement | Other |
| PAX3 gene rearrangements associated with Alveolar Rhabdomyosarcoma measurement | PAX3 gene rearrangements associated with Alveolar Rhabdomyosarcoma measurement | Other |
| PKU monitoring | PKU monitoring | Other |
| PLT | PLT | Other |
| Paediatric Audiology Services | Paediatric Audiology Services: Otoscopy | Other |
| Pan B cell marker | Pan B cell marker | Other |
| Pan B cell marker, follicular dendritic cells | Pan B cell marker, follicular dendritic cells | Other |
| Pan Cytokeratin, epithelial cells | Pan Cytokeratin, epithelial cells | Other |
| Pan T cell marker | Pan T-cell marker | Other |
| Pancreatic islet delta cells | Pancreatic islet delta cells | Other |
| Pancreatic islets, T cells, neuroectodermal tumour cells | Pancreatic islets, T cells, neuroectodermal tumour cells | Other |
| Pancreatic islets, neurons, neuroendocrine cells | Pancreatic islets, neurons, neuroendocrine cells | Other |
| Parathyroid Hormone (PTH) | Parathyroid Hormone (PTH) | Other |
| Particle repositioning manœuvres | Particle repositioning manœuvres | Other |
| Parvovirus Infected cells | Parvovirus infected cells | Other |
| Peptide hormone gastrin | Peptide hormone gastrin | Other |
| Performance Test | Performance Test | Other |
| Performance Testing | Performance Testing | Other |
| Peripheral T lymphocytes | Peripheral T-Lymphocytes | Other |
| Phenobarbitone | Phenobarbitone | Other |
| Phenytoin measurement | Phenytoin measurement | Other |
| Phosphate | Phosphate | Other |
| Phytanic acid and Pristanic acid | Phytanic acid and Pristanic acid | Other |
| Pigeon( Streptopelia spp ) | Pigeon( Streptopelia spp ) | Other |
| Pigmentosa R33 (RPGR, exon ORF15 only) | Pigmentosa R33 (RPGR, exon ORF15 only) | Other |
| Plasma Viscosity | Plasma Viscosity | Other |
| Plasmalogens | Plasmalogens | Other |
| Platelet Glycoprotein Assay | Platelet Glycoprotein Assay | Other |
| Platelet aggregation and nucleotide release | Platelet aggregation and nucleotide release | Other |
| Play Audiometry | Play Audiometry | Other |
| Pneumocystis carinii infected cells | Pneumocystis carinii infected cells | Other |
| Polyoma virus | Polyoma virus | Other |
| Posaconazole | Posaconazole | Other |
| Possible X-linked Retinitis | Possible X-linked Retinitis | Other |
| Posturography | Posturography | Other |
| Potential (VEMP) Testing vHIT | Potential (VEMP) Testing vHIT | Other |
| Pre Transplant HLA specific allo antibody screening Post Transplant HLA specific allo antibody monitoring | Pre Transplant HLA specific allo antibody screening Post Transplant HLA specific allo antibody monitoring | Other |
| Prednisolone | Prednisolone | Other |
| Prenatal/Postnatal diagnosis of aneuploidy (chromosomes 13, 18, 21 or sex chromosomes) | Prenatal/Postnatal diagnosis of aneuploidy (chromosomes 13, 18, 21 or sex chromosomes) | Other |
| Preparation and examination of tissue to identify or exclude morphological & cytological abnormalities measurement | Preparation and examination of tissue to identify or exclude morphological & cytological abnormalities measurement | Other |
| Preparation and examination to identify or exclude morphological & cytological abnormalities | Preparation and examination to identify or exclude morphological & cytological abnormalities | Other |
| Preparation and examination to identify or exclude morphological & cytological abnormalities Electron Microscopy | Preparation and examination to identify or exclude morphological & cytological abnormalities Electron Microscopy | Other |
| Preparation and examination to identify or exclude morphological & cytological abnormalities measurement | Preparation and examination to identify or exclude morphological & cytological abnormalities measurement | Other |
| Pro Collagen Type 3 | Pro Collagen Type 3 | Other |
| Procollagen N Peptide type 1 measurement | Procollagen N Peptide type 1 measurement | Other |
| Production of extracted, amplified and purified DNA for the purposes of subsequent identification by | Production of extracted, amplified and purified DNA for the purposes of subsequent identification by | Other |
| Progesterone marker | Progesterone marker | Other |
| Progesterone sFlt-1 (Solublefms-like tyrosine kinase-1) sFlt-1/ PIGF ratio | Progesterone sFlt-1 (Solublefms-like tyrosine kinase-1) sFlt-1/ PIGF ratio | Other |
| Prolactin | Prolactin | Other |
| Proliferation Marker | Proliferation marker | Other |
| Prostate adenocarcinoma | Prostate adenocarcinoma | Other |
| Prostate carcinoma | Prostate carcinoma | Other |
| Prostatic Adenocarcinoma | Prostatic adenocarcinoma | Other |
| Prostatic Intraepithelial Neoplasia | Prostatic intraepithelial neoplasia | Other |
| Protein | Protein | Other |
| Protein C Activity | Protein C activity | Other |
| Proteoglycans, acid mucins, hyaluronic acid measurement | Proteoglycans, acid mucins, hyaluronic acid measurement | Other |
| Prothrombin Time | Prothrombin Time | Other |
| Prothrombin Time / INR | Prothrombin time / INR | Other |
| Prothrombin time correction with normal plasma | Prothrombin time correction with normal plasma | Other |
| Pure Tone Audiometry | Pure Tone Audiometry | Other |
| Quantitation of white blood cells | Quantitation of white blood cells | Other |
| Quantitative antifungal assay for therapeutic drug monitoring: Flucytosine | Quantitative antifungal assay for therapeutic drug monitoring: Flucytosine | Other |
| Quantitative detection of Creatinine | Quantitative detection of Creatinine | Other |
| Quantitative detection of clinically relevant nucleic acid sequence variants for the following: Non-Small Cell Lung Cancer (somatic mutations, - tumour samples) (EGFR) | Quantitative detection of clinically relevant nucleic acid sequence variants for the following: Non-Small Cell Lung Cancer (somatic mutations, - tumour samples) (EGFR) | Other |
| Quantitative monitoring of gene expression for: RUNX1/RUNX1T1 PML::-RARA (t15;17) CBFB::-MYH11 nv(16) and t16;16) NPM1 | Quantitative monitoring of gene expression for: RUNX1/RUNX1T1 PML::-RARA (t15;17) CBFB::-MYH11 nv(16) and t16;16) NPM1 | Other |
| RBC | RBC | Other |
| RDW-CV | RDW-CV | Other |
| RESPONSE | RESPONSE: | Other |
| RNA extraction and quality check for subsequent in house analysis (see below), referral to specialist centres and longterm storage | RNA extraction and quality check for subsequent in house analysis (see below), referral to specialist centres and longterm storage | Other |
| Real Ear Measurement | Real Ear Measurement | Other |
| Real Ear to Coupler Differences | Real Ear to Coupler Differences | Other |
| Rectal Histochemistry for the identification of Identification of Neurons in rectal biopsy – Absence indicates Hirsch sprung Disease | Rectal Histochemistry for the identification of Identification of Neurons in rectal biopsy – Absence indicates Hirsch sprung Disease | Other |
| Red Blood Cell Count | Red blood cell count | Other |
| Red Cell Distribution Width | Red Cell Distribution width | Other |
| Reed-Sternberg, Hodgkin’s lymphoma and ALCL | Reed-Sternberg, Hodgkin’s lymphoma and ALCL | Other |
| Removal of Melanin | Removal of melanin | Other |
| Renal cell carcinomas | Renal cell carcinomas | Other |
| Renin | Renin | Other |
| Reproductive Medicine Disorders | Reproductive medicine disorders | Other |
| Reptilase Time measurement | Reptilase Time measurement | Other |
| Respiratory Muscle Assessment | Respiratory Muscle Assessment: • Inspiratory & expiratory pressures | Other |
| Response to Therapeutic | Response to therapeutic | Other |
| Responsiveness | Responsiveness: Bronchial Challenge Testing: • Methacholine • Mannitol | Other |
| Reticulin Fibres | Reticulin fibres | Other |
| Reticulocytes measurement | Reticulocytes measurement | Other |
| Retinoblastoma (RB1) | Retinoblastoma (RB1) | Other |
| Rh groups, antigen D and antibody screen using Ortho Surgiscreen 3 cell panel | Rh groups, antigen D and antibody screen using Ortho Surgiscreen 3 cell panel | Other |
| Rhabdoid Tumour (SMARCB1/ LZTR1) | Rhabdoid Tumour (SMARCB1/ LZTR1) | Other |
| Rhabdoid tumour | Rhabdoid tumour | Other |
| Rhabdoid tumours | Rhabdoid tumours | Other |
| Rhabdomyosarcoma | Rhabdomyosarcoma | Other |
| Rhabdomyosarcoma measurement | Rhabdomyosarcoma measurement | Other |
| Ristocetin Cofactor level measurement | Ristocetin Cofactor level measurement | Other |
| Rivoroxaban | Rivoroxaban | Other |
| SDH Activity | SDH Activity | Other |
| SS18 gene rearrangements associated with Synovial sarcoma | SS18 gene rearrangements associated with Synovial sarcoma | Other |
| Salivary Cortisol and cortisone | Salivary Cortisol and cortisone | Other |
| Sample preparation and referral to ISO 15189:2022 accredited laboratory (UKAS reference 8393) for the purposes of HPV DNA test using Cobas 8800 | Sample preparation and referral to ISO 15189:2022 accredited laboratory (UKAS reference 8393) for the purposes of HPV DNA test using Cobas 8800 | Other |
| Sanger Sequencing by External source and Pyrosequencing (if applicable) | Sanger Sequencing by External source and Pyrosequencing (if applicable) | Other |
| Sarcoma measurement | Sarcoma measurement | Other |
| Sarcomas, melanomas, lymphomas | Sarcomas, melanomas, lymphomas | Other |
| Schwannomatosis (LZTR1, SMARCB1) | Schwannomatosis (LZTR1, SMARCB1) | Other |
| Schwannomatosis; Atypical Familial | Schwannomatosis; Atypical Familial | Other |
| Sebaceous carcinoma | Sebaceous carcinoma | Other |
| Sedimentation Rate | Sedimentation Rate | Other |
| Semi-automated autoimmunity including: ANCA** | Semi-automated autoimmunity including: ANCA** | Other |
| Sequencing by External source and Pyrosequencing (if applicable) | Sequencing by External source and Pyrosequencing (if applicable) | Other |
| Serum Electrophoresis | Serum Electrophoresis | Other |
| Services | Services: Otoscopy | Other |
| Sex Linked: Xg(a) | Sex Linked: Xg(a) | Other |
| Sickle Solubility test for presence of sickle haemoglobin (HbS) | Sickle solubility test for presence of sickle haemoglobin (HbS) | Other |
| Sickle cell and Thalassemia screen for beta trait and evidence of alpha trait | Sickle cell and Thalassemia screen for beta trait and evidence of alpha trait | Other |
| Simple epithelium, pneumocytes | Simple epithelium, pneumocytes | Other |
| Simple glandular/transitional epithelium | Simple glandular/transitional epithelium | Other |
| Skeletal and cardiac muscle | Skeletal and cardiac muscle | Other |
| Skin Ab (Pemphigus/Pemphigoid)* * | Skin Ab (Pemphigus/Pemphigoid)* * | Other |
| Skin Allergen Testing | Skin Allergen Testing | Other |
| Small bowel / stomach epithelium / adenocarcinomas / columnar epithelium | Small bowel / stomach epithelium / adenocarcinomas / columnar epithelium | Other |
| Smooth Muscle | Smooth muscle | Other |
| Smooth Muscle Ab (SMA)** | Smooth Muscle Ab (SMA)** | Other |
| Smooth Muscle Cells | Smooth Muscle Cells | Other |
| Smooth muscle, skeletal cardiac | Smooth muscle, skeletal cardiac | Other |
| Sodium measurement | Sodium measurement | Other |
| Solitary fibrous tumour measurement | Solitary fibrous tumour measurement | Other |
| Specific Antibodies for the purpose of clinical diagnosis for Transplantation (HLA-A, -B, Cw, -DR, -DQ, DP) | Specific Antibodies for the purpose of clinical diagnosis for Transplantation (HLA-A, -B, Cw, -DR, -DQ, DP) | Other |
| Specific IgE | Specific IgE: Box-elder | Other |
| Sphingomyelinase (Niemann Pick type A/B, acid sphingomyelinase deficiency, ASMD) | Sphingomyelinase (Niemann Pick type A/B, acid sphingomyelinase deficiency, ASMD) | Other |
| Spirochaetes | Spirochaetes | Other |
| Static Lung Volumes | Static Lung Volumes: • Gas Dilution • Plethysmography | Other |
| Statstrip | Statstrip | Other |
| Statstrip 79 (Dual) | Statstrip 79 (Dual) | Other |
| Subset of IgG Immunoglobulin | Subset of IgG Immunoglobulin | Other |
| Succinylacetone | Succinylacetone | Other |
| Succinylacetone (to investigate tyrosinameia type 1) | Succinylacetone (to investigate tyrosinameia type 1) | Other |
| Sugar Chromatography | Sugar chromatography | Other |
| Sulphite | Sulphite | Other |
| Sweat Analysis | Sweat Analysis | Other |
| Synovial Sarcoma | Synovial sarcoma | Other |
| Systemic and Airway | Systemic and Airway | Other |
| T & B Cells (Pan-lymphocyte marker) | T & B Cells (Pan-lymphocyte marker) | Other |
| T Cell Activation Markers | T Cell Activation Markers | Other |
| T Cells, myeloid cells | T Cells, myeloid cells | Other |
| T and B cell Isolation | T and B cell Isolation | Other |
| T cells, neoplastic B cells, , T cell lymphomas | T cells, neoplastic B cells, , T cell lymphomas | Other |
| T follicular helper cells, follicular lymphoma | T follicular helper cells, follicular lymphoma | Other |
| T-cell Receptor Excision | T-cell Receptor Excision | Other |
| TFE3 gene rearrangements associated with Renal cell carcinoma and alveolar soft part tumour | TFE3 gene rearrangements associated with Renal cell carcinoma and alveolar soft part tumour | Other |
| TMP/GFR | TmP/GFR | Other |
| Tacrolimus | Tacrolimus | Other |
| Test | Test) | Other |
| Testing | Testing | Other |
| Therapeutic Drug | Therapeutic Drug | Other |
| Therapy | Therapy | Other |
| Thiopurine metabolites | Thiopurine metabolites: Thioguanine nucleotides BC-SP-S-106 (6GTN) Methylmercaptopurine nucleotides (6MMPN) Dionex ultimate 3000 UHPLC with thermo scientific Q Exactive High Resolution Accurate MS | Other |
| Threshold | Threshold | Other |
| Thrombin Time | Thrombin Time | Other |
| Thrombocytopenia (HIT) | Thrombocytopenia (HIT) | Other |
| Thromboplastin Time (APTT) | Thromboplastin Time (APTT) | Other |
| Thyroid Peroxidase | Thyroid Peroxidase | Other |
| Thyroid follicular cells, thyroid follicular carcinoma | Thyroid follicular cells, thyroid follicular carcinoma | Other |
| Thyroid, thyroid tumours | Thyroid, thyroid tumours | Other |
| Tinctorial stains for the demonstration of: Cells (nuclei and cytoplasm) | Tinctorial stains for the demonstration of: Cells (nuclei and cytoplasm) | Other |
| Tinctorial stains for the demonstration of : Cells (nuclei and cytoplasm) and micro organisms | Tinctorial stains for the demonstration of : Cells (nuclei and cytoplasm) and micro organisms | Other |
| Tinnitus Handicap Inventory | Tinnitus Handicap Inventory | Other |
| Tinnitus: Outcome Questionnaire: Tinnitus Functional Index Tinnitus Counselling | Tinnitus: Outcome Questionnaire: • Tinnitus Functional Index Tinnitus Counselling | Other |
| Total Cholesterol/HDL Ratio | Total Cholesterol/HDL Ratio | Other |
| Total Homocysteine | Total homocysteine | Other |
| Total Protein measurement | Total Protein measurement | Other |
| Toxoplasmosis | Toxoplasmosis | Other |
| Trans-tubular potassium gradient | Trans-tubular potassium gradient | Other |
| Transferrin Saturation | Transferrin saturation | Other |
| Transient Evoked | Transient Evoked | Other |
| Translocation renal cell CA/ Alveolar soft sarcoma | Translocation renal cell CA/ Alveolar soft sarcoma | Other |
| Transplantation Engraftment | Transplantation Engraftment | Other |
| Transporter 8 (ZnT8) | Transporter 8 (ZnT8) | Other |
| Triple negative breast cancer | Triple negative breast cancer | Other |
| Trophoblasts, Germ cell tumour marker | Trophoblasts, Germ cell tumour marker | Other |
| Troponin T measurement | Troponin T measurement | Other |
| Tubercle bacilli measurement | Tubercle bacilli measurement | Other |
| Tumour Suppressor Gene | Tumour suppressor gene | Other |
| Tumours of lung, endometrium and ovarian origin | Tumours of lung, endometrium and ovarian origin | Other |
| Tympanometry | Tympanometry | Other |
| Tympanometry & Reflex Testing | Tympanometry & Reflex testing | Other |
| Tympanometry & Reflex Testing with Interpretation of Results | Tympanometry & Reflex Testing with interpretation of results | Other |
| Tympanometry with Interpretation of Results | Tympanometry with Interpretation of Results | Other |
| Typing – | Typing – | Other |
| Tyrosine | Tyrosine | Other |
| UREA | Urea | Other |
| USP6 gene rearrangements associated with Aneurysmal bone cyst | USP6 gene rearrangements associated with Aneurysmal bone cyst | Other |
| Unaided & Aided Sound Field | Unaided & Aided Sound Field | Other |
| Unaided & Aided Testing | Unaided & Aided Testing | Other |
| Urate (Uric Acid) | Urate (Uric Acid) | Other |
| Urine HMMA/creatinine ratio | Urine HMMA/creatinine ratio | Other |
| Urine HVA/creatinine ratio | Urine HVA/creatinine ratio | Other |
| Urine Protein/Creatinine Ratio | Urine Protein/Creatinine Ratio | Other |
| Urine Urate/Creatinine ratio | Urine Urate/Creatinine ratio | Other |
| Urine albumin creatinine ratio | Urine albumin creatinine ratio | Other |
| Urine calcium/creatinine clearance ratio | Urine calcium/creatinine clearance ratio | Other |
| Urine fractional excretion of sodium | Urine fractional excretion of sodium | Other |
| Urine hCG | Urine hCG | Other |
| Urine multistix: Glucose, Bilirubin, Ketone, Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite, Leucocytes | Urine multistix: Glucose, Siemens Clinitek Enzymatic reaction Bilirubin, Ketone, Specific PO-SOP-10 Gravity, Blood, pH, Protein, Urobilinogen, Nitrite, Leucocytes | Other |
| Urine noradrenaline/creatinine ratio measurement | Urine noradrenaline/creatinine ratio measurement | Other |
| Using Griffols IAT and ENZ panels panel to ID: D, C, E, c, e, C w , K, k, Kp a , Js a , Fy a , Fy b , Jk a Jk b , Le a , Le b , P 1 , M, N, S, s, Lu a , Co b , Xg a | Using Griffols IAT and ENZ panels panel to ID: D, C, E, c, e, C w , K, k, Kp a , Js a , Fy a , Fy b , Jk a Jk b , Le a , Le b , P 1 , M, N, S, s, Lu a , Co b , Xg a | Other |
| VRBQ Questionnaire | VRBQ Questionnaire | Other |
| Valproate | Valproate | Other |
| Vascular endothelial cells and Haematopoietic cells | Vascular endothelial cells and Haematopoietic cells | Other |
| Vascular endothelial cells, Infantile haemangioma | Vascular endothelial cells, Infantile haemangioma | Other |
| Vascular endothelial cells, T cells and some soft tissue | Vascular endothelial cells, T cells and some soft tissue | Other |
| Ventilation Control at Rest | Ventilation Control at Rest | Other |
| Very Long Chain Fatty Acids | Very Long Chain Fatty Acids | Other |
| Vestibular | Vestibular: Vestibular History Taking | Other |
| Vestibular Evoked Myogenic | Vestibular Evoked Myogenic | Other |
| Vestibular Rehabilitation | Vestibular Rehabilitation | Other |
| Videonystagmography | Videonystagmography | Other |
| Visual Reinforcement Audiometry | Visual Reinforcement Audiometry | Other |
| Vitamin D metabolites | Vitamin D metabolites | Other |
| Vitamin E measurement | Vitamin E measurement | Other |
| Voriconazole | Voriconazole | Other |
| WT1 gene rearrangements associated with desmoplastic small round cell tumours | WT1 gene rearrangements associated with desmoplastic small round cell tumours | Other |
| Wax Removal- Crocodile Forceps | Wax Removal- Crocodile Forceps | Other |
| Wax Removal- Jason Horne Probe | Wax Removal- Jason Horne Probe | Other |
| Wax Removal- Suction Clearance | Wax Removal- Suction Clearance | Other |
| Werfen | Werfen | Other |
| Willebrands Activity | Willebrands Activity | Other |
| Wilms tumour measurement | Wilms tumour measurement | Other |
| X Chem8 | X Chem8 | Other |
| X X | X X | Other |
| Xanthochromia | Xanthochromia | Other |
| AMMONIA | Ammonia | Spectroscopy (XRF, ICP, AAS) |
| Aldosterone | Aldosterone | Spectroscopy (XRF, ICP, AAS) |
| Alkaline Phosphatase | Alkaline Phosphatase | Spectroscopy (XRF, ICP, AAS) |
| Bence Jones Protein | Bence-Jones Protein | Spectroscopy (XRF, ICP, AAS) |
| Bilirubin | Bilirubin | Spectroscopy (XRF, ICP, AAS) |
| Calprotectin | Calprotectin | Spectroscopy (XRF, ICP, AAS) |
| Copper | Copper | Spectroscopy (XRF, ICP, AAS) |
| Creatinine | Creatinine | Spectroscopy (XRF, ICP, AAS) |
| Cystatin C | Cystatin C | Spectroscopy (XRF, ICP, AAS) |
| D Dimer | D-Dimer | Spectroscopy (XRF, ICP, AAS) |
| Ethanol | Ethanol | Spectroscopy (XRF, ICP, AAS) |
| Ferritin | Ferritin | Spectroscopy (XRF, ICP, AAS) |
| Free T3 | Free T3 | Spectroscopy (XRF, ICP, AAS) |
| Free T4 | Free T4 | Spectroscopy (XRF, ICP, AAS) |
| Glucose | Glucose | Spectroscopy (XRF, ICP, AAS) |
| Insulin Like Growth factor 1 | Insulin-like growth factor-1 | Spectroscopy (XRF, ICP, AAS) |
| Iron | Iron | Spectroscopy (XRF, ICP, AAS) |
| Ketone | Ketone | Spectroscopy (XRF, ICP, AAS) |
| Lipase | Lipase | Spectroscopy (XRF, ICP, AAS) |
| Lithium | Lithium | Spectroscopy (XRF, ICP, AAS) |
| Magnesium | Magnesium | Spectroscopy (XRF, ICP, AAS) |
| Oestradiol | Oestradiol | Spectroscopy (XRF, ICP, AAS) |
| Paracetamol | Paracetamol | Spectroscopy (XRF, ICP, AAS) |
| Sex Hormone Binding Globulin | Sex Hormone-binding Globulin | Spectroscopy (XRF, ICP, AAS) |
| TSH | TSH | Spectroscopy (XRF, ICP, AAS) |
| Total IGE | Total-IgE | Spectroscopy (XRF, ICP, AAS) |
| Transferrin | Transferrin | Spectroscopy (XRF, ICP, AAS) |
| Fungi | Fungi | Sterility Testing |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.